Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 2/2009

01-04-2009 | SSIEM Symposium 2008

Tolerance to fast: rational and practical evaluation in children with hypoketonaemia

Author: J. H. Walter

Published in: Journal of Inherited Metabolic Disease | Issue 2/2009

Login to get access

Summary

Prolonged fasting in children with disorder of fat oxidation or ketone body synthesis can lead not only to hypoglycaemia but also to the accumulation of toxic metabolites. The length of time such patients can be safely fasted is important information for caregivers. Most children with MCAD deficiency when well can tolerate ‘normal’ periods without food, but in more severe disorders such as LCHAD deficiency even these may be associated with acute or chronic damage. Guidelines have been published for safe fasting periods in MCAD but not in other conditions. In the absence of such recommendations, a rational approach must be based on an understanding of the normal physiology of fasting in children of different ages and the pathophysiology associated with the child’s particular disorder. Intercurrent infections pose a particular risk and may significantly reduce fasting tolerance.
Literature
go back to reference Bonnefont JP, Specola NB, Vassault A, et al (1990) The fasting test in paediatrics: application to the diagnosis of pathological hypo- and hyperketotic states. Eur J Pediatr 150(2): 80–85. doi: 10.1007/BF02072043.PubMedCrossRef Bonnefont JP, Specola NB, Vassault A, et al (1990) The fasting test in paediatrics: application to the diagnosis of pathological hypo- and hyperketotic states. Eur J Pediatr 150(2): 80–85. doi: 10.​1007/​BF02072043.PubMedCrossRef
go back to reference Dixon M, Champion M (2008) Medium chain acyl CoA dehydrogenase deficiency: dietary management guidelines for dietitians. British Inherited Metabolic Disease Group. Available at: www.bimdg.org.uk. Dixon M, Champion M (2008) Medium chain acyl CoA dehydrogenase deficiency: dietary management guidelines for dietitians. British Inherited Metabolic Disease Group. Available at: www.​bimdg.​org.​uk.
go back to reference Gillingham MB, Weleber RG, Neuringer M, et al (2005) Effect of optimal dietary therapy upon visual function in children with long-chain 3-hydroxyacyl CoA dehydrogenase and trifunctional protein deficiency. Mol Genet Metab 86(1–2): 124–133. doi: 10.1016/j.ymgme.2005.06.001.PubMedCrossRef Gillingham MB, Weleber RG, Neuringer M, et al (2005) Effect of optimal dietary therapy upon visual function in children with long-chain 3-hydroxyacyl CoA dehydrogenase and trifunctional protein deficiency. Mol Genet Metab 86(1–2): 124–133. doi: 10.​1016/​j.​ymgme.​2005.​06.​001.PubMedCrossRef
go back to reference Heales SJ, Thompson GN, Massoud AF, Rahman S, Halliday D, Leonard JV (1994) Production and disposal of medium-chain fatty acids in children with medium-chain acyl-CoA dehydrogenase deficiency. J Inherit Metab Dis 17(1): 74–80. doi: 10.1007/BF00735398.PubMedCrossRef Heales SJ, Thompson GN, Massoud AF, Rahman S, Halliday D, Leonard JV (1994) Production and disposal of medium-chain fatty acids in children with medium-chain acyl-CoA dehydrogenase deficiency. J Inherit Metab Dis 17(1): 74–80. doi: 10.​1007/​BF00735398.PubMedCrossRef
go back to reference Jakobs C, Kneer J, Martin D, et al (1997) In vivo stable isotope studies in three patients affected with mitochondrial fatty acid oxidation disorders: limited diagnostic use of 1-13C fatty acid breath test using bolus technique. Eur J Pediatr 156(Supplement 1): S78–S82. doi: 10.1007/PL00014278.CrossRef Jakobs C, Kneer J, Martin D, et al (1997) In vivo stable isotope studies in three patients affected with mitochondrial fatty acid oxidation disorders: limited diagnostic use of 1-13C fatty acid breath test using bolus technique. Eur J Pediatr 156(Supplement 1): S78–S82. doi: 10.​1007/​PL00014278.CrossRef
go back to reference Spiekerkotter U, Schwahn B, Korall H, Trefz FK, Andresen BS, Wendel U (2000) Very-long-chain acyl-coenzyme A dehydrogenase (VLCAD) deficiency: monitoring of treatment by carnitine/acylcarnitine analysis in blood spots. Acta Paediatr 89(4): 492–495. doi: 10.1080/080352500750028267.PubMedCrossRef Spiekerkotter U, Schwahn B, Korall H, Trefz FK, Andresen BS, Wendel U (2000) Very-long-chain acyl-coenzyme A dehydrogenase (VLCAD) deficiency: monitoring of treatment by carnitine/acylcarnitine analysis in blood spots. Acta Paediatr 89(4): 492–495. doi: 10.​1080/​0803525007500282​67.PubMedCrossRef
go back to reference Stanley CA, Bennett MJ, Mayatepek E (2006) Disorders of mitochondrial fatty acid oxidation and related metabolic pathways. In: Fernandes J et al, eds. Inborn Metabolic Diseases, 4th edn., pp. 175–190. Berlin: Springer-Verlag. Stanley CA, Bennett MJ, Mayatepek E (2006) Disorders of mitochondrial fatty acid oxidation and related metabolic pathways. In: Fernandes J et al, eds. Inborn Metabolic Diseases, 4th edn., pp. 175–190. Berlin: Springer-Verlag.
Metadata
Title
Tolerance to fast: rational and practical evaluation in children with hypoketonaemia
Author
J. H. Walter
Publication date
01-04-2009
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 2/2009
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-009-1087-y

Other articles of this Issue 2/2009

Journal of Inherited Metabolic Disease 2/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.